Our leadership team
Our highly skilled team has a combined 80+ years of experience in development, adaptation of processes to large-scale bioreactor systems and manufacturing on a variety of AAV serotypes, including novel engineered capsids.
Combined 80+ years of experience
Our team has a demonstrated track record of achievement in viral vector manufacturing with multiple AAV serotypes and scales. We deeply understand regulatory requirements and are focused on innovation.
